Evaluation of morbidity in Schistosoma mansoni-positive primary and secondary school children after four years of mass drug administration of praziquantel in western Kenya

Table 4 Organomegaly, wasting and stunting prevalence in Schistosoma mansoni-positive primary school children at baseline and year five

	Schistosoma mansoni positive, n (%)
	Baseline	Year five	P-value
All 6–12 years old	n = 117	n = 32
Hepatomegaly alone	26 (22.2)	6 (18.8)	0.810
Hepatosplenomegaly	36 (30.8)	9 (28.1)	0.831
Splenomegaly alone	25 (21.4)	10 (31.3)	0.248
Normal	30 (25.6)	7 (21.9)	0.818
Stunting	5 (4.4)	0	0.585
Wasting	1 (0.9)	0	0.999
6–12 years old malaria positive	n = 60	n = 18
Hepatomegaly	11 (18.3)	0	0.059
Hepatosplenomegaly	23 (38.3)	7 (38.9)	0.999
Splenomegaly	15 (25.0)	8 (44.4)	0.143
Normal	11 (18.3)	3 (16.7)	0.999
Stunting	3 (5.0)	0	0.999
Wasting	1 (1.7)	0 (0.0)	0.999
6–12 years old malaria negative	n = 57	n = 14
Hepatomegaly	15 (26.3)	6 (42.9)	0.326
Hepatosplenomegaly	13 (22.8)	2 (14.3)	0.719
Splenomegaly	10 (17.5)	2 (14.3)	0.999
Normal	19 (33.3)	4 (28.6)	0.999
Stunting	2 (3.5)	0	0.999
Wasting	0	0	0.999

ISSN: 2049-9957